Area of research
Physiology · Pharmacology
Research interest
Research interests include Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Bioinformatics and Genomic Networks, and Dementia and Cognitive Impairment Research.
Modifiable risk factors for stroke, dementia and late-life depression: a systematic review and DALY-weighted risk factors for a composite outcome
Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial
Single-cell multiregion dissection of Alzheimer’s disease
Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial
Gene therapy for CNS disorders: modalities, delivery and translational challenges
Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner
Engineered 3D human neurovascular model of Alzheimer's disease to study vascular dysfunction
A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
Early modulation of the gut microbiome by female sex hormones alters amyloid pathology and microglial function
The predictive validity of a Brain Care Score for late-life depression and a composite outcome of dementia, stroke, and late-life depression: data from the UK Biobank cohort
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
The neuroimmune axis of Alzheimer’s disease
APOE4 impairs the microglial response in Alzheimer’s disease by inducing TGFβ-mediated checkpoints
Adult hippocampal neurogenesis in Alzheimer’s disease: A roadmap to clinical relevance
The predictive validity of a Brain Care Score for dementia and stroke: data from the UK Biobank cohort
A Photolabile Curcumin‐Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer's Disease Treatment**
Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease
Accelerating the in vitro emulation of Alzheimer’s disease-associated phenotypes using a novel 3D blood-brain barrier neurosphere co-culture model
Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models
Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
Primary prevention recommendations to reduce the risk of cognitive decline
Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias
Enhanced activity of Alzheimer disease-associated variant of protein kinase Cα drives cognitive decline in a mouse model
Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer’s Disease
Infection and inflammation: New perspectives on Alzheimer's disease